<DOC>
	<DOCNO>NCT02232802</DOCNO>
	<brief_summary>This open-label , randomised , single-dose , 2-way crossover study determine comparative bioavailability enoxaparin sodium Chemi Enoxaparin s.c. ( 80 mg/0.8mL ) reference IMP , ClexaneÂ® s.c. ( 80 mg/0.8mL ) , follow single dose administration healthy male female subject .</brief_summary>
	<brief_title>Bioavailability Study Enoxaparin Sodium Chemi Clexane s.c .</brief_title>
	<detailed_description>Each subject receive treatment two separate treatment period fast condition . Each dose day male subject separate washout period least 7 day . The study comprise pre-study screen ( within 14 day first dose ) , follow 2 Treatment Periods ( 1 2 ) . During treatment period , subject reside Simbec even dosing ( Day 1 ) , least 36 h post dose ( even Day 2 ) . On admission ( Day -1 ) , subject provide urine sample drug abuse screen ; sample also test confirm negative pregnancy result female volunteer . A single dose randomise treatment give morning Day 1 follow overnight fast blood PK/PD sample collect pre-dose 36 h post dose ( 14 sample ) . Safety also evaluate specify time throughout study . The post study visit conduct Day 2 ( 36 h post-dose ) Treatment Period 2 .</detailed_description>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Healthy male female volunteer 18 55 year age . Subject BMI 1830 ( Body Mass Index = Body weight ( kg ) / [ Height ( ) ] 2 ) Subject clinically significant abnormal serum biochemistry , haematology , coagulation factor urine examination value within 14 day first dose . Subject clinically significant abnormality 12lead electrocardiogram ( ECG ) vital sign determine within 14 day first dose . Subject hypersensitivity idiosyncratic reaction enoxaparin and/or low molecular weight heparin , and/or pork product . Subject relevant history presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . Female subject pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>